Fundraising Fox
Soltego
Newton, US · Founded 2017 · Delaware corporation
Find your way into Soltego
474 people in our graph can introduce you to the Soltego team.
Sign up to see every warm intro you have to Soltego
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Soltego team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SOLTÉGO is a bio-cosmetics company developing skin care products aimed at protecting and repairing skin from sun-induced damage. Its team includes chemists, formulators, skin pharmacologists, and cosmetic safety experts.
Founders & leadership
Soltego was founded in 2017 by Nathanael Gray.
NG
Nathanael GrayCo-Founder
PS
Philippe SchaisonChief Executive OfficerPhilippe Schaison holds an MBA from HEC and a doctorate in pharmacy from University of Paris V. He previously led the US Aesthetic & Dermatology division at Allergan, served as global president of travel retail and regional president for Latin America and Middle East/Africa at Clarins, and held VP and board roles in skin care at Johnson & Johnson.
IE
Irina ErenburgNamed on SEC filing
DF
David FisherCo-Founder
CD
Craig DrillNamed on SEC filing
DF
Dr. Fisher
Reported raises · per SEC filings
Form D private placements$7.3M disclosed across 2 rounds · 2018–2019
▶$6.7MraisedApr 2019 · 4 investors · BiotechnologyRule 506(b)
▶$6.7MraisedApr 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Irina ErenburgExecutive Officer, Director
- Nathanael S GrayDirector
- David FisherDirector
- Philippe SchaisonExecutive Officer, Director
- Craig DrillDirector
- Offering amount
- $6.7M
- Amount sold
- $6.7M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$600KraisedDec 2018 · 2 investors · BiotechnologyRule 506(b)
▶$600KraisedDec 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Irina ErenburgExecutive Officer, Director
- Nathanael GrayDirector
- Philippe SchaisonExecutive Officer, Director
- David FisherDirector
- Offering amount
- $1M
- Amount sold
- $600K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
LighthorsetxLight Horse Therapeutics is a drug discovery company applying scientific expertise and innovation to advance healthcare through collaborative development. The company focuses on transforming drug discovery processes and bringing treatments to patients.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as Soltego.
Frequently asked questions
- What does Soltego do?
- SOLTÉGO is a bio-cosmetics company developing skin care products aimed at protecting and repairing skin from sun-induced damage. Its team includes chemists, formulators, skin pharmacologists, and cosmetic safety experts.
- Who founded Soltego?
- Soltego was founded by Nathanael Gray in 2017.
- How much funding has Soltego raised?
- Soltego has disclosed $7.3M raised across 2 rounds.
- Where is Soltego headquartered?
- Soltego is headquartered in Newton, US.